Enrolling by invitationEarly Phase 1NCT06434935

Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit

Studying Cold agglutinin disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vascudyne, Inc.
Principal Investigator
Adrian Ebner, MD
Italian Hospital Asuncion Paraguay
Intervention
CABA(combination_product)
Enrollment
5 target
Eligibility
45-75 years · All sexes
Timeline
2024 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06434935 on ClinicalTrials.gov

Other trials for Cold agglutinin disease

Additional recruiting or active studies for the same condition.

See all trials for Cold agglutinin disease →

← Back to all trials